205 related articles for article (PubMed ID: 31499501)
1. Androgens in Cushing's Syndrome.
Arnaldi G; Martino M
Front Horm Res; 2019; 53():77-91. PubMed ID: 31499501
[TBL] [Abstract][Full Text] [Related]
2. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
Kaltsas GA; Korbonits M; Isidori AM; Webb JA; Trainer PJ; Monson JP; Besser GM; Grossman AB
Clin Endocrinol (Oxf); 2000 Oct; 53(4):493-500. PubMed ID: 11012575
[TBL] [Abstract][Full Text] [Related]
3. Differential diagnosis of hyperandrogenism in women with polycystic ovary syndrome.
RachoĊ D
Exp Clin Endocrinol Diabetes; 2012 Apr; 120(4):205-9. PubMed ID: 22421986
[TBL] [Abstract][Full Text] [Related]
4. Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.
Azziz R; Black V; Hines GA; Fox LM; Boots LR
J Clin Endocrinol Metab; 1998 Jul; 83(7):2317-23. PubMed ID: 9661602
[TBL] [Abstract][Full Text] [Related]
5. Adrenal hyperandrogenism is induced by fetal androgen excess in a rhesus monkey model of polycystic ovary syndrome.
Zhou R; Bird IM; Dumesic DA; Abbott DH
J Clin Endocrinol Metab; 2005 Dec; 90(12):6630-7. PubMed ID: 16174719
[TBL] [Abstract][Full Text] [Related]
6. Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess.
Moran C; Reyna R; Boots LS; Azziz R
Fertil Steril; 2004 Jan; 81(1):126-31. PubMed ID: 14711555
[TBL] [Abstract][Full Text] [Related]
7. DHEA, DHEAS and PCOS.
Goodarzi MO; Carmina E; Azziz R
J Steroid Biochem Mol Biol; 2015 Jan; 145():213-25. PubMed ID: 25008465
[TBL] [Abstract][Full Text] [Related]
8. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
[TBL] [Abstract][Full Text] [Related]
9. Adrenal androgen excess and body mass index in polycystic ovary syndrome.
Moran C; Arriaga M; Arechavaleta-Velasco F; Moran S
J Clin Endocrinol Metab; 2015 Mar; 100(3):942-50. PubMed ID: 25514100
[TBL] [Abstract][Full Text] [Related]
10. The adrenal and polycystic ovary syndrome.
Yildiz BO; Azziz R
Rev Endocr Metab Disord; 2007 Dec; 8(4):331-42. PubMed ID: 17932770
[TBL] [Abstract][Full Text] [Related]
11. Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione.
O'Reilly MW; Taylor AE; Crabtree NJ; Hughes BA; Capper F; Crowley RK; Stewart PM; Tomlinson JW; Arlt W
J Clin Endocrinol Metab; 2014 Mar; 99(3):1027-36. PubMed ID: 24423344
[TBL] [Abstract][Full Text] [Related]
12. Screening for Cushing's syndrome in obese women with and without polycystic ovary syndrome.
Putignano P; Bertolini M; Losa M; Cavagnini F
J Endocrinol Invest; 2003 Jun; 26(6):539-44. PubMed ID: 12952368
[TBL] [Abstract][Full Text] [Related]
13. Increased clearance of cortisol by 5beta-reductase in a subgroup of women with adrenal hyperandrogenism in polycystic ovary syndrome.
Gambineri A; Forlani G; Munarini A; Tomassoni F; Cognigni GE; Ciampaglia W; Pagotto U; Walker BR; Pasquali R
J Endocrinol Invest; 2009 Mar; 32(3):210-8. PubMed ID: 19542736
[TBL] [Abstract][Full Text] [Related]
14. The adrenal cortex and virilization.
McKenna TJ; Cunningham SK; Loughlin T
Clin Endocrinol Metab; 1985 Nov; 14(4):997-1020. PubMed ID: 3002682
[TBL] [Abstract][Full Text] [Related]
15. Adrenal androgen production capacity remains high up to menopause in women with polycystic ovary syndrome.
Puurunen J; Piltonen T; Jaakkola P; Ruokonen A; Morin-Papunen L; Tapanainen JS
J Clin Endocrinol Metab; 2009 Jun; 94(6):1973-8. PubMed ID: 19318449
[TBL] [Abstract][Full Text] [Related]
16. Hyperandrogenism in adolescents.
Witchel SF
Adolesc Med; 2002 Feb; 13(1):89-99, vi-vii. PubMed ID: 11841957
[TBL] [Abstract][Full Text] [Related]
17. Androgen secretion in ectopic ACTH syndrome and in Cushing's disease: modifications before and after surgery.
Barbetta L; Dall'Asta C; Re T; Colombo P; Travaglini P; Ambrosi B
Horm Metab Res; 2001 Oct; 33(10):596-601. PubMed ID: 11607879
[TBL] [Abstract][Full Text] [Related]
18. 11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome.
O'Reilly MW; Kempegowda P; Jenkinson C; Taylor AE; Quanson JL; Storbeck KH; Arlt W
J Clin Endocrinol Metab; 2017 Mar; 102(3):840-848. PubMed ID: 27901631
[TBL] [Abstract][Full Text] [Related]
19. Food-dependent androgen and cortisol secretion by a gastric inhibitory polypeptide-receptor expressive adrenocortical adenoma leading to hirsutism and subclinical Cushing's syndrome: in vivo and in vitro studies.
Tsagarakis S; Tsigos C; Vassiliou V; Tsiotra P; Pratsinis H; Kletsas D; Trivizas P; Nikou A; Mavromatis T; Sotsiou F; Raptis S; Thalassinos N
J Clin Endocrinol Metab; 2001 Feb; 86(2):583-9. PubMed ID: 11158012
[TBL] [Abstract][Full Text] [Related]
20. Dissociation of adrenal androgen and cortisol secretion in Cushing's syndrome.
Cunningham SK; McKenna TJ
Clin Endocrinol (Oxf); 1994 Dec; 41(6):795-800. PubMed ID: 7889616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]